Background: Current endogenous indicators utilised in avian medicine are not sensitive enough to detect renal disease in its early stages. Alternative markers ought to be examined as a result. The aim is to investigate the accuracy of limited-sampling models for glomerular filtration rate (GFR) in adult seagulls using plasma clearance of iohexol (IOX).

Results: We compared the GFR estimated from the plasma concentration of IOX at 3 sampling times, known as limited sampling models, with that estimated from the plasma concentration of IOX at 6 sampling times (reference model). The reference model's mean ± SD for GFR was 6.88 ± 2.46 mL/min/kg and did not considerably differ from the GFR predicted by the limited-sampling models. Model 4, in which GFR was estimated using plasma IOX concentrations at 5, 15, and 90 min after IOX administration, had the smallest GFR bias compared to the reference model.

Conclusions: The findings revealed that IOX plasma clearance was a reliable, accurate, and clinically applicable approach to calculating seagull GFR. This strategy might help with the validation and subsequent development of clinical renal biomarkers.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12917-024-04454-5DOI Listing

Publication Analysis

Top Keywords

plasma clearance
12
estimated plasma
12
glomerular filtration
8
filtration rate
8
clearance iohexol
8
limited-sampling models
8
gfr estimated
8
plasma concentration
8
concentration iox
8
iox sampling
8

Similar Publications

Background: Lamotrigine clearance can change drastically in pregnant women with epilepsy (PWWE) making it difficult to assess the need for dosing adjustments. Our objective was to characterize lamotrigine pharmacokinetics in PWWE during pregnancy and postpartum along with a control group of nonpregnant women with epilepsy (NPWWE).

Methods: The Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) study was a prospective, observational, 20 site, cohort study conducted in the United States (December 2012 and February 2016).

View Article and Find Full Text PDF

Unlabelled: Genome- and epigenome-wide association studies have associated variants and methylation status of carnitine palmitoyltransferase 1a (CPT1a) to reductions in very low-density lipoprotein (VLDL) cholesterol and triglyceride levels. We report significant associations between the presence of SNPs and reductions in plasma cholesterol, as well as positive associations between hepatic Cpt1a expression and plasma cholesterol levels across inbred mouse strains. Mechanistic studies show that both wild type and human apolipoprotein B100 (apoB)-transgenic mice with liver-specific deletion of (LKO) display lower circulating apoB levels consistent with reduced LDL-cholesterol (LDL-C) and LDL particle number.

View Article and Find Full Text PDF

Evaluation of glomerular filtration rate estimation through plasma clearance of iohexol in seagulls (Larus michahellis).

BMC Vet Res

January 2025

Department of Veterinary Sciences, Veterinary Teaching Hospital "Mario Modenato", University of Pisa, via Livornese snc, San Piero a Grado, Pisa, Italy.

Background: Current endogenous indicators utilised in avian medicine are not sensitive enough to detect renal disease in its early stages. Alternative markers ought to be examined as a result. The aim is to investigate the accuracy of limited-sampling models for glomerular filtration rate (GFR) in adult seagulls using plasma clearance of iohexol (IOX).

View Article and Find Full Text PDF

Background: Nivolumab is an immune checkpoint inhibitor (ICI) that selectively inhibits programmed cell death protein 1 activation, restoring antitumor immunity. ICIs are indicated for various types of advanced solid tumors; however, not all patients benefit from them, and tools that could be used in the clinic to predict response to treatment represent an unmet need. Here we describe the development of a new population pharmacokinetic (PPK) model in patients treated with nivolumab in clinical trials.

View Article and Find Full Text PDF

Gastrin-releasing peptide receptors (GRPRs) overexpressed in many cancers are known as promising biomarkers to target tumors such as prostate, breast, and lung cancers. As the early diagnosis of the cancers can serve for better treatment of the patients, [In]In-DOTA-Pip-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2 ([In]In-RM2) was prepared using an in-house developed Sn/In generator. 0.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!